Regulation of TRAIL-induced apoptosis by transcription factors

被引:59
作者
Göke, R [1 ]
Göke, A
Göke, B
Chen, YH
机构
[1] Univ Penn, Sch Med, Inst Human Gene Therapy, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA
[2] Univ Bern, Dept Gastroenterol, CH-3010 Bern, Switzerland
关键词
TNF; PPAR-gamma; NF-kappa B; Jurkat cells; apoptosis;
D O I
10.1006/cimm.2000.1650
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a newly identified member of the TNF family. Unlike many other members of the TNF family, TRAIL selectively induces apoptosis of tumor cells, but not normal cells. The mechanisms whereby TRAIL-induced apoptosis is regulated in various cell types are not clear. We report here that the peroxisome proliferator-activated receptor (PPAR)-gamma and nuclear factor (NF)-kappa B play distinct roles in regulating TRAIL-induced apoptosis. Activation of PPAR-gamma by its agonist pioglitazone significantly enhanced TRAIL-induced apoptosis, This was associated with inhibition of proliferation and cell cycle progression. On the other hand, inhibition of NF-kappa B by sulfasalazine also significantly enhanced TRAIL-induced apoptosis, These results strongly suggest that while transcription factor PPAR-gamma promotes TRAIL-induced apoptosis, NF-kappa B inhibits it. Thus, PPAR-gamma agonists and NF-kappa B inhibitors are potent enhancers of TRAIL-induced apoptosis. (C) 2000 Academic Press.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 20 条
  • [1] Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
    Chinetti, G
    Griglio, S
    Antonucci, M
    Torra, IP
    Delerive, P
    Majd, Z
    Fruchart, JC
    Chapman, J
    Najib, J
    Staels, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) : 25573 - 25580
  • [2] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [3] Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
    Emery, JG
    McDonnell, P
    Burke, MB
    Deen, KC
    Lyn, S
    Silverman, C
    Dul, E
    Appelbaum, ER
    Eichman, C
    DiPrinzio, R
    Dodds, RA
    James, IE
    Rosenberg, M
    Lee, JC
    Young, PR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) : 14363 - 14367
  • [4] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA
    FORMAN, BM
    TONTONOZ, P
    CHEN, J
    BRUN, RP
    SPIEGELMAN, BM
    EVANS, RM
    [J]. CELL, 1995, 83 (05) : 803 - 812
  • [5] INTERACTION OF THE PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR AND RETINOID X-RECEPTOR
    GEARING, KL
    GOTTLICHER, M
    TEBOUL, M
    WIDMARK, E
    GUSTAFSSON, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (04) : 1440 - 1444
  • [6] TRAIL: a molecule with multiple receptors and control mechanisms
    Griffith, TS
    Lynch, DH
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 559 - 563
  • [7] Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis
    Morrison, RF
    Farmer, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) : 17088 - 17097
  • [8] TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
    Pan, GH
    Ni, J
    Yu, GL
    Wei, YF
    Dixit, VM
    [J]. FEBS LETTERS, 1998, 424 (1-2) : 41 - 45
  • [9] The receptor for the cytotoxic ligand TRAIL
    Pan, GH
    ORourke, K
    Chinnaiyan, AM
    Gentz, R
    Ebner, R
    Ni, J
    Dixit, VM
    [J]. SCIENCE, 1997, 276 (5309) : 111 - 113
  • [10] Mechanisms by which thiazolidinediones enhance insulin action
    Reginato, MJ
    Lazar, MA
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (01) : 9 - 13